Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 103
Filtrar
Más filtros

Banco de datos
Tipo del documento
Intervalo de año de publicación
1.
Clin Infect Dis ; 73(11): e3788-e3796, 2021 12 06.
Artículo en Inglés | MEDLINE | ID: mdl-32710751

RESUMEN

BACKGROUND: An improved understanding of childhood pneumonia etiology is required to inform prevention and treatment strategies. Lung aspiration is the gold standard specimen for pneumonia diagnostics. We report findings from analyses of lung and pleural aspirates collected in the Pneumonia Etiology Research for Child Health (PERCH) study. METHODS: The PERCH study enrolled children aged 1-59 months hospitalized with World Health Organization-defined severe or very severe pneumonia in 7 countries in Africa and Asia. Percutaneous transthoracic lung aspiration (LA) and pleural fluid (PF) aspiration was performed on a sample of pneumonia cases with radiological consolidation and/or PF in 4 countries. Venous blood and nasopharyngeal/oropharyngeal swabs were collected from all cases. Multiplex quantitative polymerase chain reaction (PCR) and routine microbiologic culture were applied to clinical specimens. RESULTS: Of 44 LAs performed within 3 days of admission on 622 eligible cases, 13 (30%) had a pathogen identified by either culture (5/44) or by PCR (11/29). A pathogen was identified in 12/14 (86%) PF specimens tested by either culture (9/14) or PCR (9/11). Bacterial pathogens were identified more frequently than viruses. All but 1 of the cases with a virus identified were coinfected with bacterial pathogens. Streptococcus pneumoniae (9/44 [20%]) and Staphylococcus aureus (7/14 [50%]) were the predominant pathogens identified in LA and PF, respectively. CONCLUSIONS: Bacterial pathogens predominated in this selected subgroup of PERCH participants drawn from those with radiological consolidation or PF, with S. pneumoniae and S. aureus the leading pathogens identified.


Asunto(s)
Percas , Neumonía , Animales , Teorema de Bayes , Estudios de Casos y Controles , Niño , Salud Infantil , Preescolar , Países en Desarrollo , Humanos , Lactante , Pulmón , Gravedad del Paciente , Neumonía/diagnóstico , Neumonía/etiología , Neumonía/prevención & control , Factores de Riesgo , Staphylococcus aureus
2.
Environ Res ; 195: 110025, 2021 04.
Artículo en Inglés | MEDLINE | ID: mdl-32791251

RESUMEN

BACKGROUND: Deficits in child growth are associated with poor cognitive outcomes and an increased risk for infection and mortality globally. One hundred forty million people are chronically exposed to arsenic from contaminated drinking water worldwide. While arsenic exposure has been associated with cognitive developmental delays in children, there is limited research on the association between arsenic exposure and growth deficits in young children. PURPOSE: The objective of this study was to assess the association between chronic arsenic exposure and deficits in growth among children under 5 years in a rural setting in Bangladesh. METHODS: Urinary arsenic measurements were collected from 465 children between the ages of 28 days-59 months in rural Matlab, Bangladesh, and analyzed by graphite furnace atomic absorption. Height and weight measurements were collected from children according to World Health Organization child growth standards. A z-score cutoff2 standard deviations below the mean was used to define stunting (height-for-age z-score), underweight (weight-for-age z-score), and wasting (weight-for-height z-score). RESULTS: Children under 5 years with urinary arsenic concentrations in the third tertile (greater than 31 µg per liter (µg/L)) had a two times higher odds of being underweight after adjustment for age, creatinine, paternal education, breastfeeding, number of individuals using the same sleeping room, and physician-diagnosed pneumonia (Odds Ratio (OR): 2.29 (95% Confidence Interval (CI): 1.16, 4.52)). Children under 2 years of age had a two times higher odds of being wasted after adjustment for age, creatinine, paternal education, breastfeeding, number of individuals using the same sleeping room, and physician-diagnosed pneumonia (OR: 2.85 (95% CI: 1.18, 6.89)). CONCLUSIONS: These findings suggest that arsenic exposure is associated with an increased odds of being wasted and underweight among young children in rural Bangladesh.


Asunto(s)
Arsénico , Agua Potable , Arsénico/análisis , Bangladesh/epidemiología , Niño , Preescolar , Agua Potable/análisis , Femenino , Humanos , Lactante , Población Rural , Delgadez/epidemiología
3.
Clin Infect Dis ; 70(6): 1050-1057, 2020 03 03.
Artículo en Inglés | MEDLINE | ID: mdl-31111870

RESUMEN

BACKGROUND: In 2015, pneumonia remained the leading cause of mortality in children aged 1-59 months. METHODS: Data from 1802 human immunodeficiency virus (HIV)-negative children aged 1-59 months enrolled in the Pneumonia Etiology Research for Child Health (PERCH) study with severe or very severe pneumonia during 2011-2014 were used to build a parsimonious multivariable model predicting mortality using backwards stepwise logistic regression. The PERCH severity score, derived from model coefficients, was validated on a second, temporally discrete dataset of a further 1819 cases and compared to other available scores using the C statistic. RESULTS: Predictors of mortality, across 7 low- and middle-income countries, were age <1 year, female sex, ≥3 days of illness prior to presentation to hospital, low weight for height, unresponsiveness, deep breathing, hypoxemia, grunting, and the absence of cough. The model discriminated well between those who died and those who survived (C statistic = 0.84), but the predictive capacity of the PERCH 5-stratum score derived from the coefficients was moderate (C statistic = 0.76). The performance of the Respiratory Index of Severity in Children score was similar (C statistic = 0.76). The number of World Health Organization (WHO) danger signs demonstrated the highest discrimination (C statistic = 0.82; 1.5% died if no danger signs, 10% if 1 danger sign, and 33% if ≥2 danger signs). CONCLUSIONS: The PERCH severity score could be used to interpret geographic variations in pneumonia mortality and etiology. The number of WHO danger signs on presentation to hospital could be the most useful of the currently available tools to aid clinical management of pneumonia.


Asunto(s)
Países en Desarrollo , Neumonía , Niño , Preescolar , Femenino , VIH , Hospitales , Humanos , Lactante , Neumonía/epidemiología , Índice de Severidad de la Enfermedad
4.
Clin Infect Dis ; 69(5): 786-794, 2019 08 16.
Artículo en Inglés | MEDLINE | ID: mdl-30481269

RESUMEN

BACKGROUND: In a 2012 Phase II clinical trial, 300 Bangladeshi children aged 24 to 59 months with no prior influenza vaccine exposure were randomized to receive a single intranasally-administered dose of either trivalent, Russian-backbone, live, attenuated influenza vaccine (LAIV) or placebo. Protocol-defined analyses, presented in the companion manuscript, demonstrate decreased viral detection and immunogenicity for A/H1N1pdm09, relative to the A/H3N2 and B strains. This post hoc analysis of the trial data aims to investigate the LAIV strain differences by testing the hypothesis that preexisting humoral and mucosal immunity may influence viral recovery and immune responses after LAIV receipt. METHODS: We used logistic regressions to evaluate the relations between markers of preexisting immunity (ie, hemagglutination inhibition [HAI], microneutralization, and immunoglobulin G and immunoglobulin A (both serum and mucosal antibodies) and LAIV viral recovery in the week post-vaccination. We then tested for potential effect modification by baseline HAI titers (ie, <10 versus ≥10) and week 1 viral recovery on the LAIV-induced serum and mucosal immune responses, measured between days 0 and 21 post-vaccination. RESULTS: Higher levels of preexisting immunity to influenza A/H3N2 and B were strongly associated with strain-specific prevention of viral shedding upon LAIV receipt. While evidence of LAIV immunogenicity was observed for all 3 strains, the magnitudes of immune responses were most pronounced in children with no evidence of preexisting HAI and in those with detectable virus. CONCLUSIONS: The results provide evidence for a bidirectional association between viral replication and immunity, and underscore the importance of accounting for preexisting immunity when evaluating virologic and immunologic responses to LAIVs. CLINICAL TRIALS REGISTRATION: NCT01625689.


Asunto(s)
Anticuerpos Antivirales/sangre , Vacunas contra la Influenza/inmunología , Gripe Humana/prevención & control , Administración Intranasal , Anticuerpos Antivirales/inmunología , Bangladesh , Preescolar , Estudios Transversales , Femenino , Pruebas de Inhibición de Hemaglutinación , Humanos , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Subtipo H3N2 del Virus de la Influenza A/inmunología , Gripe Humana/inmunología , Masculino , Vacunación , Vacunas Atenuadas/inmunología , Esparcimiento de Virus
5.
Clin Infect Dis ; 69(5): 777-785, 2019 08 16.
Artículo en Inglés | MEDLINE | ID: mdl-30481272

RESUMEN

BACKGROUND: We evaluated a Russian-backbone, live, attenuated influenza vaccine (LAIV) for immunogenicity and viral shedding in a randomized, placebo-controlled trial among Bangladeshi children. METHODS: Healthy children received a single, intranasal dose of LAIV containing the 2011-2012 recommended formulation or placebo. Nasopharyngeal wash (NPW) specimens were collected on days 0, 2, 4, and 7. Reverse transcription polymerase chain reactions and sequencing identified the influenza virus (vaccine or wild-type). On days 0 and 21, blood specimens were collected to assess immunogenicity using hemagglutination inhibition, microneutralization, and immunoglobulin A (IgA) and G enzyme-linked immunosorbent assays (ELISAs); NPW specimens were also collected to assess mucosal immunogenicity using kinetic IgA ELISA. RESULTS: We enrolled 300 children aged 24 through 59 months in the immunogenicity and viral shedding analyses. Among children receiving LAIV, 45% and 67% shed A/H3N2 and B vaccine strains, respectively. No child shed A/H1N1 vaccine strain. There were significantly higher day 21 geometric mean titers (GMTs) for the LAIV, as compared to the placebo groups, in all immunoassays for A/H3N2 and B (log10 titer P < .0001; GMT Ratio >2.0). Among immunoassays for A/H1N1, only the mucosal IgA GMT was significantly higher than placebo at day 21 (log10 titer P = .0465). CONCLUSIONS: Children vaccinated with LAIV had serum and mucosal antibody responses to A/H3N2 and B, but only a mucosal IgA response to A/H1N1. Many children shed A/H3N2 and B vaccine strains, but none shed A/H1N1. More research is needed to determine the reason for decreased LAIV A/H1N1 immunogenicity and virus shedding. CLINICAL TRIALS REGISTRATION: NCT01625689.


Asunto(s)
Anticuerpos Antivirales/análisis , Inmunogenicidad Vacunal , Vacunas contra la Influenza/inmunología , Esparcimiento de Virus , Administración Intranasal , Bangladesh , Preescolar , Método Doble Ciego , Femenino , Humanos , Inmunoglobulina A/análisis , Subtipo H1N1 del Virus de la Influenza A/inmunología , Subtipo H3N2 del Virus de la Influenza A/inmunología , Vacunas contra la Influenza/administración & dosificación , Gripe Humana/prevención & control , Masculino , Nasofaringe/virología , Población Urbana , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/inmunología
6.
Clin Infect Dis ; 66(10): 1492-1500, 2018 05 02.
Artículo en Inglés | MEDLINE | ID: mdl-29186364

RESUMEN

Background: Oseltamivir has been used to treat children with influenza for nearly 2 decades, with treatment currently approved for infants aged ≥2 weeks. However, efficacy and safety remain controversial. Newer randomized, placebo-controlled trials (RCTs), not included in previous meta-analyses, can add to the evidence base. Methods: We conducted a systematic review to identify RCTs of oseltamivir therapy in children. We obtained individual patient data and examined protocol-defined outcomes. We then conducted a 2-stage, random-effects meta-analysis to determine the efficacy of treatment in reducing the duration of illness, estimated using differences in restricted mean survival time (RMST) by treatment group. We also examined complications and safety. Results: We identified 5 trials that included 2561 patients in the intention-to-treat (ITT) and 1598 in the intention-to-treat infected (ITTI) populations. Overall, oseltamivir treatment significantly reduced the duration of illness in the ITTI population (RMST difference, -17.6 hours; 95% confidence interval [CI], -34.7 to -0.62 hours). In trials that enrolled patients without asthma, the difference was larger (-29.9 hours; 95% CI, -53.9 to -5.8 hours). Risk of otitis media was 34% lower in the ITTI population. Vomiting was the only adverse event with a significantly higher risk in the treatment group. Conclusions: Despite substantial heterogeneity in pediatric trials, we found that treatment with oseltamivir significantly reduced the duration of illness in those with influenza and lowered the risk of developing otitis media. Alternative endpoints may be required to evaluate the efficacy of oseltamivir in pediatric patients with asthma.


Asunto(s)
Antivirales/efectos adversos , Antivirales/uso terapéutico , Gripe Humana/tratamiento farmacológico , Oseltamivir/efectos adversos , Oseltamivir/uso terapéutico , Adolescente , Niño , Humanos , Ensayos Clínicos Controlados Aleatorios como Asunto
7.
Lancet ; 390(10098): 946-958, 2017 Sep 02.
Artículo en Inglés | MEDLINE | ID: mdl-28689664

RESUMEN

BACKGROUND: We have previously estimated that respiratory syncytial virus (RSV) was associated with 22% of all episodes of (severe) acute lower respiratory infection (ALRI) resulting in 55 000 to 199 000 deaths in children younger than 5 years in 2005. In the past 5 years, major research activity on RSV has yielded substantial new data from developing countries. With a considerably expanded dataset from a large international collaboration, we aimed to estimate the global incidence, hospital admission rate, and mortality from RSV-ALRI episodes in young children in 2015. METHODS: We estimated the incidence and hospital admission rate of RSV-associated ALRI (RSV-ALRI) in children younger than 5 years stratified by age and World Bank income regions from a systematic review of studies published between Jan 1, 1995, and Dec 31, 2016, and unpublished data from 76 high quality population-based studies. We estimated the RSV-ALRI incidence for 132 developing countries using a risk factor-based model and 2015 population estimates. We estimated the in-hospital RSV-ALRI mortality by combining in-hospital case fatality ratios with hospital admission estimates from hospital-based (published and unpublished) studies. We also estimated overall RSV-ALRI mortality by identifying studies reporting monthly data for ALRI mortality in the community and RSV activity. FINDINGS: We estimated that globally in 2015, 33·1 million (uncertainty range [UR] 21·6-50·3) episodes of RSV-ALRI, resulted in about 3·2 million (2·7-3·8) hospital admissions, and 59 600 (48 000-74 500) in-hospital deaths in children younger than 5 years. In children younger than 6 months, 1·4 million (UR 1·2-1·7) hospital admissions, and 27 300 (UR 20 700-36 200) in-hospital deaths were due to RSV-ALRI. We also estimated that the overall RSV-ALRI mortality could be as high as 118 200 (UR 94 600-149 400). Incidence and mortality varied substantially from year to year in any given population. INTERPRETATION: Globally, RSV is a common cause of childhood ALRI and a major cause of hospital admissions in young children, resulting in a substantial burden on health-care services. About 45% of hospital admissions and in-hospital deaths due to RSV-ALRI occur in children younger than 6 months. An effective maternal RSV vaccine or monoclonal antibody could have a substantial effect on disease burden in this age group. FUNDING: The Bill & Melinda Gates Foundation.


Asunto(s)
Hospitalización/estadística & datos numéricos , Modelos Estadísticos , Virus Sincitiales Respiratorios/aislamiento & purificación , Infecciones del Sistema Respiratorio/epidemiología , Preescolar , Países en Desarrollo , Salud Global , Mortalidad Hospitalaria , Humanos , Incidencia , Lactante , Recién Nacido , Factores de Riesgo
8.
Clin Infect Dis ; 65(11): 1914-1920, 2017 Nov 13.
Artículo en Inglés | MEDLINE | ID: mdl-29028980

RESUMEN

BACKGROUND: Influenza causes substantial morbidity in children worldwide, although influenza vaccine is seldom used in low-resource settings. More information on the clinical presentation of influenza and the efficacy of vaccine is needed to inform policy. METHODS: In 2013 we conducted a randomized, placebo-controlled clinical trial of live attenuated influenza vaccine (LAIV) in children aged 24-59 months in Bangladesh (N = 1761). If participants met prespecified specimen collection criteria, we collected nasopharyngeal washes for testing by singleplex reverse-transcription polymerase chain reaction (RT-PCR) for laboratory-confirmed influenza virus infection (LCI). A panel of RT-PCR assays was used to detect noninfluenza respiratory viruses. Primary efficacy results have been reported. In this analysis of prespecified and post hoc objectives from the trial, we compared signs and symptoms between LCI and non-LCI cases and estimated the efficacy of LAIV against moderate-to-severe LCI and other prespecified non-LCI clinical outcomes including all-cause pneumonia and acute otitis media. RESULTS: The most common signs and symptoms of LCI were fever, cough, and runny nose. The combination of subjective fever and cough had a 63% sensitivity for LCI. The combination of measured fever, cough, and runny nose was most specific (90%) but had low sensitivity (32%) for LCI. The efficacy of LAIV against vaccine-strain moderate-to-severe LCI was 56.7% (95% confidence interval, 9.5%-79.2%). No statistically significant vaccine efficacy was found against the non-laboratory-confirmed clinical outcomes. CONCLUSIONS: It was not possible to distinguish LCI from noninfluenza viral infections on clinical evaluations alone in this population of Bangladeshi children. LAIV was efficacious against moderate-to-severe LCI. CLINICAL TRIALS REGISTRATION: NCT01797029.


Asunto(s)
Vacunas contra la Influenza/inmunología , Gripe Humana/epidemiología , Gripe Humana/inmunología , Orthomyxoviridae/aislamiento & purificación , Potencia de la Vacuna , Administración Intranasal , Bangladesh/epidemiología , Preescolar , Tos/epidemiología , Tos/etiología , Países en Desarrollo/estadística & datos numéricos , Femenino , Fiebre/epidemiología , Fiebre/etiología , Humanos , Vacunas contra la Influenza/administración & dosificación , Vacunas contra la Influenza/efectos adversos , Gripe Humana/complicaciones , Gripe Humana/virología , Masculino , Nasofaringe/virología , Orthomyxoviridae/genética , Orthomyxoviridae/inmunología , Otitis Media/epidemiología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Vacunas Atenuadas/administración & dosificación , Vacunas Atenuadas/inmunología
9.
Clin Infect Dis ; 64(suppl_3): S205-S212, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575354

RESUMEN

Many pneumonia etiology case-control studies exclude controls with respiratory illness from enrollment or analyses. Herein we argue that selecting controls regardless of respiratory symptoms provides the least biased estimates of pneumonia etiology. We review 3 reasons investigators may choose to exclude controls with respiratory symptoms in light of epidemiologic principles of control selection and present data from the Pneumonia Etiology Research for Child Health (PERCH) study where relevant to assess their validity. We conclude that exclusion of controls with respiratory symptoms will result in biased estimates of etiology. Randomly selected community controls, with or without respiratory symptoms, as long as they do not meet the criteria for case-defining pneumonia, are most representative of the general population from which cases arose and the least subject to selection bias.


Asunto(s)
Diseño de Investigaciones Epidemiológicas , Neumonía/etiología , Proyectos de Investigación , Infecciones del Sistema Respiratorio , Niño , Interpretación Estadística de Datos , Femenino , Humanos , Masculino , Estudios Multicéntricos como Asunto , Neumonía/epidemiología , Neumonía Bacteriana/epidemiología , Neumonía Viral/epidemiología , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/etiología , Factores de Riesgo , Sesgo de Selección
10.
Clin Infect Dis ; 64(suppl_3): S213-S227, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575370

RESUMEN

In pneumonia, specimens are rarely obtained directly from the infection site, the lung, so the pathogen causing infection is determined indirectly from multiple tests on peripheral clinical specimens, which may have imperfect and uncertain sensitivity and specificity, so inference about the cause is complex. Analytic approaches have included expert review of case-only results, case-control logistic regression, latent class analysis, and attributable fraction, but each has serious limitations and none naturally integrate multiple test results. The Pneumonia Etiology Research for Child Health (PERCH) study required an analytic solution appropriate for a case-control design that could incorporate evidence from multiple specimens from cases and controls and that accounted for measurement error. We describe a Bayesian integrated approach we developed that combined and extended elements of attributable fraction and latent class analyses to meet some of these challenges and illustrate the advantage it confers regarding the challenges identified for other methods.


Asunto(s)
Teorema de Bayes , Modelos Estadísticos , Neumonía/epidemiología , Neumonía/etiología , Investigación Biomédica , Estudios de Casos y Controles , Niño , Salud Infantil , Técnicas de Diagnóstico del Sistema Respiratorio , Diseño de Investigaciones Epidemiológicas , Humanos , Neumonía/diagnóstico , Neumonía Bacteriana/diagnóstico , Neumonía Bacteriana/epidemiología , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Sensibilidad y Especificidad
11.
Clin Infect Dis ; 64(suppl_3): S228-S237, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575355

RESUMEN

BACKGROUND.: Variable adherence to standardized case definitions, clinical procedures, specimen collection techniques, and laboratory methods has complicated the interpretation of previous multicenter pneumonia etiology studies. To circumvent these problems, a program of clinical standardization was embedded in the Pneumonia Etiology Research for Child Health (PERCH) study. METHODS.: Between March 2011 and August 2013, standardized training on the PERCH case definition, clinical procedures, and collection of laboratory specimens was delivered to 331 clinical staff at 9 study sites in 7 countries (The Gambia, Kenya, Mali, South Africa, Zambia, Thailand, and Bangladesh), through 32 on-site courses and a training website. Staff competency was assessed throughout 24 months of enrollment with multiple-choice question (MCQ) examinations, a video quiz, and checklist evaluations of practical skills. RESULTS.: MCQ evaluation was confined to 158 clinical staff members who enrolled PERCH cases and controls, with scores obtained for >86% of eligible staff at each time-point. Median scores after baseline training were ≥80%, and improved by 10 percentage points with refresher training, with no significant intersite differences. Percentage agreement with the clinical trainer on the presence or absence of clinical signs on video clips was high (≥89%), with interobserver concordance being substantial to high (AC1 statistic, 0.62-0.82) for 5 of 6 signs assessed. Staff attained median scores of >90% in checklist evaluations of practical skills. CONCLUSIONS.: Satisfactory clinical standardization was achieved within and across all PERCH sites, providing reassurance that any etiological or clinical differences observed across the study sites are true differences, and not attributable to differences in application of the clinical case definition, interpretation of clinical signs, or in techniques used for clinical measurements or specimen collection.


Asunto(s)
Técnicas de Laboratorio Clínico/normas , Neumonía/diagnóstico , Neumonía/etiología , Manejo de Especímenes/normas , Bangladesh , Niño , Interpretación Estadística de Datos , Diseño de Investigaciones Epidemiológicas , Femenino , Gambia , Hospitales , Humanos , Internacionalidad , Kenia , Masculino , Malí , Estudios Multicéntricos como Asunto/normas , Neumonía/tratamiento farmacológico , Neumonía/prevención & control , Neumonía Bacteriana/diagnóstico , Neumonía Bacteriana/epidemiología , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Sudáfrica , Tailandia , Zambia
12.
Clin Infect Dis ; 64(suppl_3): S301-S308, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575356

RESUMEN

BACKGROUND.: Induced sputum (IS) may provide diagnostic information about the etiology of pneumonia. The safety of this procedure across a heterogeneous population with severe pneumonia in low- and middle-income countries has not been described. METHODS.: IS specimens were obtained as part a 7-country study of the etiology of severe and very severe pneumonia in hospitalized children <5 years of age. Rigorous clinical monitoring was done before, during, and after the procedure to record oxygen requirement, oxygen saturation, respiratory rate, consciousness level, and other evidence of clinical deterioration. Criteria for IS contraindications were predefined and serious adverse events (SAEs) were reported to ethics committees and a central safety monitor. RESULTS.: A total of 4653 IS procedures were done among 3802 children. Thirteen SAEs were reported in relation to collection of IS, or 0.34% of children with at least 1 IS specimen collected (95% confidence interval, 0.15%-0.53%). A drop in oxygen saturation that required supplemental oxygen was the most common SAE. One child died after feeding was reinitiated 2 hours after undergoing sputum induction; this death was categorized as "possibly related" to the procedure. CONCLUSIONS.: The overall frequency of SAEs was very low, and the nature of most SAEs was manageable, demonstrating a low-risk safety profile for IS collection even among severely ill children in low-income-country settings. Healthcare providers should monitor oxygen saturation and requirements during and after IS collection, and assess patients prior to reinitiating feeding after the IS procedure, to ensure patient safety.


Asunto(s)
Neumonía/diagnóstico , Neumonía/etiología , Manejo de Especímenes/efectos adversos , Esputo , Bacterias/aislamiento & purificación , Preescolar , Femenino , Humanos , Lactante , Masculino , Oxígeno , Pobreza , Manejo de Especímenes/métodos
13.
Clin Infect Dis ; 64(suppl_3): S245-S252, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575358

RESUMEN

The Pneumonia Etiology Research for Child Health study was conducted across 7 diverse research sites and relied on standardized clinical and laboratory methods for the accurate and meaningful interpretation of pneumonia etiology data. Blood, respiratory specimens, and urine were collected from children aged 1-59 months hospitalized with severe or very severe pneumonia and community controls of the same age without severe pneumonia and were tested with an extensive array of laboratory diagnostic tests. A standardized testing algorithm and standard operating procedures were applied across all study sites. Site laboratories received uniform training, equipment, and reagents for core testing methods. Standardization was further assured by routine teleconferences, in-person meetings, site monitoring visits, and internal and external quality assurance testing. Targeted confirmatory testing and testing by specialized assays were done at a central reference laboratory.


Asunto(s)
Técnicas de Laboratorio Clínico/normas , Neumonía/diagnóstico , Neumonía/etiología , Manejo de Especímenes/normas , Algoritmos , Preescolar , Exactitud de los Datos , Femenino , Infecciones por VIH , Humanos , Lactante , Masculino , Neumonía Bacteriana/diagnóstico , Neumonía Viral/diagnóstico , Control de Calidad , Estándares de Referencia , Infecciones del Sistema Respiratorio/etiología
14.
Clin Infect Dis ; 64(suppl_3): S271-S279, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575360

RESUMEN

BACKGROUND.: It is standard practice for laboratories to assess the cellular quality of expectorated sputum specimens to check that they originated from the lower respiratory tract. The presence of low numbers of squamous epithelial cells (SECs) and high numbers of polymorphonuclear (PMN) cells are regarded as indicative of a lower respiratory tract specimen. However, these quality ratings have never been evaluated for induced sputum specimens from children with suspected pneumonia. METHODS.: We evaluated induced sputum Gram stain smears and cultures from hospitalized children aged 1-59 months enrolled in a large study of community-acquired pneumonia. We hypothesized that a specimen representative of the lower respiratory tract will contain smaller quantities of oropharyngeal flora and be more likely to have a predominance of potential pathogens compared to a specimen containing mainly saliva. The prevalence of potential pathogens cultured from induced sputum specimens and quantity of oropharyngeal flora were compared for different quantities of SECs and PMNs. RESULTS.: Of 3772 induced sputum specimens, 2608 (69%) had <10 SECs per low-power field (LPF) and 2350 (62%) had >25 PMNs per LPF, measures traditionally associated with specimens from the lower respiratory tract in adults. Using isolation of low quantities of oropharyngeal flora and higher prevalence of potential pathogens as markers of higher quality, <10 SECs per LPF (but not >25 PMNs per LPF) was the microscopic variable most associated with high quality of induced sputum. CONCLUSIONS.: Quantity of SECs may be a useful quality measure of induced sputum from young children with pneumonia.


Asunto(s)
Neumonía Bacteriana/diagnóstico , Neumonía/diagnóstico , Neumonía/etiología , Neumonía/microbiología , Esputo/citología , Esputo/microbiología , Bacterias/aislamiento & purificación , Bacterias/ultraestructura , Salud Infantil , Preescolar , Infecciones Comunitarias Adquiridas/diagnóstico , Infecciones Comunitarias Adquiridas/etiología , Células Epiteliales/ultraestructura , Femenino , Hospitalización , Humanos , Lactante , Recién Nacido , Masculino , Neutrófilos/ultraestructura , Neumonía Bacteriana/microbiología , Infecciones del Sistema Respiratorio/diagnóstico , Infecciones del Sistema Respiratorio/microbiología , Saliva/citología , Saliva/microbiología , Manejo de Especímenes
15.
Clin Infect Dis ; 64(suppl_3): S262-S270, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575361

RESUMEN

BACKGROUND.: Chest radiographs (CXRs) are frequently used to assess pneumonia cases. Variations in CXR appearances between epidemiological settings and their correlation with clinical signs are not well documented. METHODS.: The Pneumonia Etiology Research for Child Health project enrolled 4232 cases of hospitalized World Health Organization (WHO)-defined severe and very severe pneumonia from 9 sites in 7 countries (Bangladesh, the Gambia, Kenya, Mali, South Africa, Thailand, and Zambia). At admission, each case underwent a standardized assessment of clinical signs and pneumonia risk factors by trained health personnel, and a CXR was taken that was interpreted using the standardized WHO methodology. CXRs were categorized as abnormal (consolidation and/or other infiltrate), normal, or uninterpretable. RESULTS.: CXRs were interpretable in 3587 (85%) cases, of which 1935 (54%) were abnormal (site range, 35%-64%). Cases with abnormal CXRs were more likely than those with normal CXRs to have hypoxemia (45% vs 26%), crackles (69% vs 62%), tachypnea (85% vs 80%), or fever (20% vs 16%) and less likely to have wheeze (30% vs 38%; all P < .05). CXR consolidation was associated with a higher case fatality ratio at 30-day follow-up (13.5%) compared to other infiltrate (4.7%) or normal (4.9%) CXRs. CONCLUSIONS.: Clinically diagnosed pneumonia cases with abnormal CXRs were more likely to have signs typically associated with pneumonia. However, CXR-normal cases were common, and clinical signs considered indicative of pneumonia were present in substantial proportions of these cases. CXR-consolidation cases represent a group with an increased likelihood of death at 30 days post-discharge.


Asunto(s)
Neumonía/diagnóstico por imagen , Neumonía/etiología , Radiografía Torácica , Australia , Bangladesh , Salud Infantil , Preescolar , Femenino , Gambia , Humanos , Lactante , Recién Nacido , Internacionalidad , Kenia , Masculino , Malí , Neumonía/epidemiología , Neumonía/mortalidad , Neumonía Bacteriana/diagnóstico por imagen , Neumonía Bacteriana/epidemiología , Neumonía Viral/diagnóstico por imagen , Neumonía Viral/epidemiología , Sudáfrica , Tailandia , Organización Mundial de la Salud , Zambia
16.
Clin Infect Dis ; 64(suppl_3): S280-S288, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575362

RESUMEN

BACKGROUND.: Sputum microscopy and culture are commonly used for diagnosing the cause of pneumonia in adults but are rarely performed in children due to difficulties in obtaining specimens. Induced sputum is occasionally used to investigate lower respiratory infections in children but has not been widely used in pneumonia etiology studies. METHODS.: We evaluated the diagnostic utility of induced sputum microscopy and culture in patients enrolled in the Pneumonia Etiology Research for Child Health (PERCH) study, a large study of community-acquired pneumonia in children aged 1-59 months. Comparisons were made between induced sputum samples from hospitalized children with radiographically confirmed pneumonia and children categorized as nonpneumonia (due to the absence of prespecified clinical and laboratory signs and absence of infiltrate on chest radiograph). RESULTS.: One induced sputum sample was available for analysis from 3772 (89.1%) of 4232 suspected pneumonia cases enrolled in PERCH. Of these, sputum from 2608 (69.1%) met the quality criterion of <10 squamous epithelial cells per low-power field, and 1162 (44.6%) had radiographic pneumonia. Induced sputum microscopy and culture results were not associated with radiographic pneumonia, regardless of prior antibiotic use, stratification by specific bacteria, or interpretative criteria used. CONCLUSIONS.: The findings of this study do not support the culture of induced sputum specimens as a diagnostic tool for pneumonia in young children as part of routine clinical practice.


Asunto(s)
Microscopía/métodos , Neumonía Bacteriana/diagnóstico , Neumonía/diagnóstico , Neumonía/etiología , Infecciones del Sistema Respiratorio/diagnóstico , Esputo/microbiología , Adulto , Bacterias/aislamiento & purificación , Bacterias/ultraestructura , Preescolar , Infecciones Comunitarias Adquiridas/diagnóstico , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Neumonía/microbiología , Neumonía Bacteriana/microbiología , Infecciones del Sistema Respiratorio/microbiología
17.
Clin Infect Dis ; 64(suppl_3): S289-S300, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575363

RESUMEN

BACKGROUND.: Sputum examination can be useful in diagnosing the cause of pneumonia in adults but is less well established in children. We sought to assess the diagnostic utility of polymerase chain reaction (PCR) for detection of respiratory viruses and bacteria in induced sputum (IS) specimens from children hospitalized with severe or very severe pneumonia. METHODS.: Among children aged 1-59 months, we compared organism detection by multiplex PCR in IS and nasopharyngeal/oropharyngeal (NP/OP) specimens. To assess whether organism presence or density in IS specimens was associated with chest radiographic evidence of pneumonia (radiographic pneumonia), we compared prevalence and density in IS specimens from children with radiographic pneumonia and children with suspected pneumonia but without chest radiographic changes or clinical or laboratory findings suggestive of pneumonia (nonpneumonia group). RESULTS.: Among 4232 cases with World Health Organization-defined severe or very severe pneumonia, we identified 1935 (45.7%) with radiographic pneumonia and 573 (13.5%) with nonpneumonia. The organism detection yield was marginally improved with IS specimens (96.2% vs 92.4% for NP/OP specimens for all viruses combined [P = .41]; 96.9% vs 93.3% for all bacteria combined [P = .01]). After accounting for presence in NP/OP specimens, no organism was detected more frequently in the IS specimens from the radiographic pneumonia compared with the nonpneumonia cases. Among high-quality IS specimens, there were no statistically significant differences in organism density, except with cytomegalovirus, for which there was a higher quantity in the IS specimens from cases with radiographic pneumonia compared with the nonpneumonia cases (median cycle threshold value, 27.9 vs 28.5, respectively; P = .01). CONCLUSIONS.: Using advanced molecular methods with IS specimens provided little additional diagnostic information beyond that obtained with NP/OP swab specimens.


Asunto(s)
Neumonía/diagnóstico , Neumonía/etiología , Reacción en Cadena en Tiempo Real de la Polimerasa , Esputo/microbiología , Bacterias/genética , Bacterias/aislamiento & purificación , Salud Infantil , Niño Hospitalizado/estadística & datos numéricos , Preescolar , Infecciones Comunitarias Adquiridas/diagnóstico , Infecciones Comunitarias Adquiridas/microbiología , Infecciones Comunitarias Adquiridas/virología , Femenino , Recursos en Salud , Humanos , Lactante , Recién Nacido , Pulmón/diagnóstico por imagen , Pulmón/microbiología , Pulmón/virología , Masculino , Técnicas de Diagnóstico Molecular , Nasofaringe/microbiología , Nasofaringe/virología , Neumonía/microbiología , Neumonía/virología , Neumonía Bacteriana/diagnóstico , Neumonía Bacteriana/microbiología , Neumonía Viral/diagnóstico , Neumonía Viral/microbiología , Sistema Respiratorio , Virus/genética , Virus/aislamiento & purificación
18.
Clin Infect Dis ; 64(suppl_3): S317-S327, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575365

RESUMEN

BACKGROUND.: Previous studies suggested an association between upper airway pneumococcal colonization density and pneumococcal pneumonia, but data in children are limited. Using data from the Pneumonia Etiology Research for Child Health (PERCH) study, we assessed this potential association. METHODS.: PERCH is a case-control study in 7 countries: Bangladesh, The Gambia, Kenya, Mali, South Africa, Thailand, and Zambia. Cases were children aged 1-59 months hospitalized with World Health Organization-defined severe or very severe pneumonia. Controls were randomly selected from the community. Microbiologically confirmed pneumococcal pneumonia (MCPP) was confirmed by detection of pneumococcus in a relevant normally sterile body fluid. Colonization density was calculated with quantitative polymerase chain reaction analysis of nasopharyngeal/oropharyngeal specimens. RESULTS.: Median colonization density among 56 cases with MCPP (MCPP cases; 17.28 × 106 copies/mL) exceeded that of cases without MCPP (non-MCPP cases; 0.75 × 106) and controls (0.60 × 106) (each P < .001). The optimal density for discriminating MCPP cases from controls using the Youden index was >6.9 log10 copies/mL; overall, the sensitivity was 64% and the specificity 92%, with variable performance by site. The threshold was lower (≥4.4 log10 copies/mL) when MCPP cases were distinguished from controls who received antibiotics before specimen collection. Among the 4035 non-MCPP cases, 500 (12%) had pneumococcal colonization density >6.9 log10 copies/mL; above this cutoff was associated with alveolar consolidation at chest radiography, very severe pneumonia, oxygen saturation <92%, C-reactive protein ≥40 mg/L, and lack of antibiotic pretreatment (all P< .001). CONCLUSIONS.: Pneumococcal colonization density >6.9 log10 copies/mL was strongly associated with MCPP and could be used to improve estimates of pneumococcal pneumonia prevalence in childhood pneumonia studies. Our findings do not support its use for individual diagnosis in a clinical setting.


Asunto(s)
Neumonía Neumocócica/diagnóstico , Neumonía Neumocócica/microbiología , Infecciones del Sistema Respiratorio/microbiología , Streptococcus pneumoniae/crecimiento & desarrollo , Streptococcus pneumoniae/aislamiento & purificación , Carga Bacteriana , Técnicas Bacteriológicas , Bangladesh , Estudios de Casos y Controles , Salud Infantil , Niño Hospitalizado , Preescolar , Femenino , Gambia , Humanos , Lactante , Recién Nacido , Kenia , Masculino , Malí , Neumonía Neumocócica/etiología , Reacción en Cadena de la Polimerasa , Infecciones del Sistema Respiratorio/diagnóstico , Sudáfrica , Streptococcus pneumoniae/genética , Tailandia , Zambia
19.
Clin Infect Dis ; 64(suppl_3): S368-S377, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575366

RESUMEN

BACKGROUND.: Antibiotic exposure and specimen volume are known to affect pathogen detection by culture. Here we assess their effects on bacterial pathogen detection by both culture and polymerase chain reaction (PCR) in children. METHODS.: PERCH (Pneumonia Etiology Research for Child Health) is a case-control study of pneumonia in children aged 1-59 months investigating pathogens in blood, nasopharyngeal/oropharyngeal (NP/OP) swabs, and induced sputum by culture and PCR. Antibiotic exposure was ascertained by serum bioassay, and for cases, by a record of antibiotic treatment prior to specimen collection. Inoculated blood culture bottles were weighed to estimate volume. RESULTS.: Antibiotic exposure ranged by specimen type from 43.5% to 81.7% in 4223 cases and was detected in 2.3% of 4863 controls. Antibiotics were associated with a 45% reduction in blood culture yield and approximately 20% reduction in yield from induced sputum culture. Reduction in yield of Streptococcus pneumoniae from NP culture was approximately 30% in cases and approximately 32% in controls. Several bacteria had significant but marginal reductions (by 5%-7%) in detection by PCR in NP/OP swabs from both cases and controls, with the exception of S. pneumoniae in exposed controls, which was detected 25% less frequently compared to nonexposed controls. Bacterial detection in induced sputum by PCR decreased 7% for exposed compared to nonexposed cases. For every additional 1 mL of blood culture specimen collected, microbial yield increased 0.51% (95% confidence interval, 0.47%-0.54%), from 2% when volume was ≤1 mL to approximately 6% for ≥3 mL. CONCLUSIONS.: Antibiotic exposure and blood culture volume affect detection of bacterial pathogens in children with pneumonia and should be accounted for in studies of etiology and in clinical management.


Asunto(s)
Antibacterianos/uso terapéutico , Bacterias/efectos de los fármacos , Bacterias/aislamiento & purificación , Neumonía Bacteriana/diagnóstico , Neumonía Bacteriana/microbiología , Antibacterianos/administración & dosificación , Bacterias/genética , Bacterias/patogenicidad , Técnicas Bacteriológicas , Estudios de Casos y Controles , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Internacionalidad , Masculino , Técnicas de Diagnóstico Molecular , Nasofaringe/microbiología , Orofaringe/microbiología , Neumonía Bacteriana/tratamiento farmacológico , Neumonía Bacteriana/etiología , Reacción en Cadena en Tiempo Real de la Polimerasa , Esputo/microbiología , Streptococcus pneumoniae/genética
20.
Clin Infect Dis ; 64(suppl_3): S328-S336, 2017 Jun 15.
Artículo en Inglés | MEDLINE | ID: mdl-28575367

RESUMEN

BACKGROUND.: There is limited information on the association between colonization density of upper respiratory tract colonizers and pathogen-specific pneumonia. We assessed this association for Haemophilus influenzae, Moraxella catarrhalis, Staphylococcus aureus, and Pneumocystis jirovecii. METHODS.: In 7 low- and middle-income countries, nasopharyngeal/oropharyngeal swabs from children with severe pneumonia and age-frequency matched community controls were tested using quantitative polymerase chain reaction (PCR). Differences in median colonization density were evaluated using the Wilcoxon rank-sum test. Density cutoffs were determined using receiver operating characteristic curves. Cases with a pathogen identified from lung aspirate culture or PCR, pleural fluid culture or PCR, blood culture, and immunofluorescence for P. jirovecii defined microbiologically confirmed cases for the given pathogens. RESULTS.: Higher densities of H. influenzae were observed in both microbiologically confirmed cases and chest radiograph (CXR)-positive cases compared to controls. Staphylococcus aureus and P. jirovecii had higher densities in CXR-positive cases vs controls. A 5.9 log10 copies/mL density cutoff for H. influenzae yielded 86% sensitivity and 77% specificity for detecting microbiologically confirmed cases; however, densities overlapped between cases and controls and positive predictive values were poor (<3%). Informative density cutoffs were not found for S. aureus and M. catarrhalis, and a lack of confirmed case data limited the cutoff identification for P. jirovecii. CONCLUSIONS.: There is evidence for an association between H. influenzae colonization density and H. influenzae-confirmed pneumonia in children; the association may be particularly informative in epidemiologic studies. Colonization densities of M. catarrhalis, S. aureus, and P. jirovecii are unlikely to be of diagnostic value in clinical settings.


Asunto(s)
Haemophilus influenzae/crecimiento & desarrollo , Moraxella catarrhalis/crecimiento & desarrollo , Pneumocystis carinii/crecimiento & desarrollo , Neumonía Bacteriana/diagnóstico , Neumonía por Pneumocystis/diagnóstico , Infecciones del Sistema Respiratorio/microbiología , Staphylococcus aureus/crecimiento & desarrollo , Preescolar , Femenino , Infecciones por Haemophilus/diagnóstico , Infecciones por Haemophilus/microbiología , Haemophilus influenzae/genética , Haemophilus influenzae/aislamiento & purificación , Humanos , Lactante , Masculino , Moraxella catarrhalis/genética , Moraxella catarrhalis/aislamiento & purificación , Infecciones por Moraxellaceae/diagnóstico , Infecciones por Moraxellaceae/microbiología , Nasofaringe/microbiología , Orofaringe/microbiología , Pneumocystis carinii/genética , Pneumocystis carinii/aislamiento & purificación , Neumonía Bacteriana/diagnóstico por imagen , Neumonía Bacteriana/etiología , Neumonía Bacteriana/microbiología , Neumonía por Pneumocystis/microbiología , Neumonía Estafilocócica/diagnóstico , Neumonía Estafilocócica/microbiología , Reacción en Cadena de la Polimerasa , Curva ROC , Staphylococcus aureus/genética , Staphylococcus aureus/aislamiento & purificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA